Oklahoma 2022 Regular Session

Oklahoma House Bill HB2660 Compare Versions

OldNewDifferences
11
22
3-HB2660 HFLR Page 1
4-BOLD FACE denotes Committee Amendments. 1
3+Req. No. 6480 Page 1 1
54 2
65 3
76 4
87 5
98 6
109 7
1110 8
1211 9
1312 10
1413 11
1514 12
1615 13
1716 14
1817 15
1918 16
2019 17
2120 18
2221 19
2322 20
2423 21
2524 22
2625 23
2726 24
2827
29-HOUSE OF REPRESENTATIVES - FLOOR VERSION
30-
3128 STATE OF OKLAHOMA
3229
3330 1st Session of the 58th Legislature (2021)
3431
35-COMMITTEE SUBSTITUTE
36-FOR
37-HOUSE BILL NO. 2660 By: Echols
32+HOUSE BILL 2660 By: Echols
3833
3934
4035
4136
4237
43-COMMITTEE SUBSTITUTE
38+AS INTRODUCED
4439
45-An Act relating to medical marijuana; amending
46-Section 4, State Question No. 788, Initiative
47-Petition No. 412 (63 O.S. Supp. 2020, Section 423),
48-which relates to medical marijuana processor
49-licensing requirements; providing for the issuance of
50-volatile and nonvolatile processor licenses; updating
51-language; amending Section 17, Chapter 11, O.S.L.
52-2019, as amended by Section 4, Chapter 312, O.S.L.
53-2019 (63 O.S. Supp. 2020, Section 427.17), which
54-relates to the Oklahoma Medical Marijuana and Patient
55-Protection Act; modifying test batch requirements for
56-licensed medical marijuana commercial growers and
57-processors; defining certain term; and providing an
58-effective date.
40+An Act relating to cannabis; creating the Oklahoma
41+Cannabis Law of 2021; providing for noncodification;
42+and providing an effective date .
43+
5944
6045
6146
6247
6348 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
64-SECTION 1. AMENDATORY Section 4, State Question No. 788,
65-Initiative Petition No. 412 (63 O.S. Supp. 2020, Section 423), is
66-amended to read as follows:
67-Section 423. A. The Oklahoma State Department of Health shall
68-within thirty (30) days of passage of this initiative, make
69-available, on their its website, in an easy-to-find location, an
49+SECTION 1. NEW LAW A new section of law not to be
50+codified in the Oklahoma Statutes reads as follows:
51+This act shall be known and may be cited as the "Oklahoma
52+Cannabis Law of 2021".
53+SECTION 2. This act shall become effective November 1, 2021.
7054
71-HB2660 HFLR Page 2
72-BOLD FACE denotes Committee Amendments. 1
73-2
74-3
75-4
76-5
77-6
78-7
79-8
80-9
81-10
82-11
83-12
84-13
85-14
86-15
87-16
88-17
89-18
90-19
91-20
92-21
93-22
94-23
95-24
96-
97-application for a medical marijuana processing processor license.
98-The Department shall be authorized to issue two types of medical
99-marijuana processor licenses:
100-1. Nonvolatile, which involves using any solvent in the
101-extraction process that is not a volatile solvent, including carbon
102-dioxide; and
103-2. Volatile, which involves using any solvent that is or
104-produces a flammable gas or vapor that, when present in the air in
105-sufficient quantities, will create explosive or ignitable mixtures
106-and may also include extraction using nonvolatile solvents or no
107-solvents.
108-The application fee for a nonvolatile or volatile medical marijuana
109-processor license shall be Two Thousand Five Hundred Dollars
110-($2,500.00) and methods. Methods of payment will shall be provided
111-on the website. The Oklahoma State Department of Health shall have
112-two (2) weeks to review the application, approve or reject the
113-application, and mail the approval/rejection letter (if rejected,
114-stating reasons for rejection) to the appli cant.
115-B. The Oklahoma State Department of Health must shall approve
116-all applications which meet the following criteria:
117-1. Applicant must be age twenty -five (25) or older;
118-2. Any applicant, applying as an individual, must show
119-residency in the State of Oklahoma;
120-
121-HB2660 HFLR Page 3
122-BOLD FACE denotes Committee Amendments. 1
123-2
124-3
125-4
126-5
127-6
128-7
129-8
130-9
131-10
132-11
133-12
134-13
135-14
136-15
137-16
138-17
139-18
140-19
141-20
142-21
143-22
144-23
145-24
146-
147-3. All applying entities must show that all members, managers,
148-and board members are Oklahoma residents;
149-4. An applying entity may show ownership of non -Oklahoma
150-residents, but that percentage ownership may not exceed twenty -five
151-percent (25%);
152-5. All applying individuals or entities must be registered to
153-conduct business in the State of Oklahoma; and
154-6. All applicants must disclose all ownership ;.
155-7. Applicant(s) An applicant with only a nonviolent felony
156-conviction(s) in the last two (2) ye ars, or any other felony
157-conviction in five (5) years, inmates, or any person currently
158-incarcerated may not qualify for a medical marijuana processing
159-processor license.
160-C. A licensed medical marijuana processor may take marijuana
161-plants and distill or p rocess these plants into concentrates,
162-edibles, and other forms for consumption. As required by subsection
163-D of this section, the Oklahoma State Department of Health will
164-shall, within sixty (60) days of passage of this initiative, make
165-available a set of standards which will be used by licensed medical
166-marijuana processors in the preparation of edible marijuana
167-products. This should be in line with current food preparation
168-guidelines and no excessive or punitive rules may be established by
169-the Oklahoma State Department of Health. Once a year, the Oklahoma
170-State Department of Health may inspect a processing operation and
171-
172-HB2660 HFLR Page 4
173-BOLD FACE denotes Committee Amendments. 1
174-2
175-3
176-4
177-5
178-6
179-7
180-8
181-9
182-10
183-11
184-12
185-13
186-14
187-15
188-16
189-17
190-18
191-19
192-20
193-21
194-22
195-23
196-24
197-
198-determine its compliance with the preparation standards. If
199-deficiencies are found, a written report of deficiency will the
200-deficiencies shall be issued to the licensed medical marijuana
201-processor. The licensed medical marijuana processor will shall have
202-one (1) month to correct the deficiency or be subject to a fine of
203-Five Hundred Dollars ($500.00) for each deficiency. A licensed
204-medical marijuana processor may sell marijuana products it creates
205-to a licensed retailer, or any other licensed medical marijuana
206-processor. Further, these sales will shall be considered wholesale
207-sales and not subject to taxation. Under no circumstances ma y a
208-licensed medical marijuana processor sell marijuana, or any
209-marijuana product, directly to a medical marijuana license holder
210-patient licensee or caregiver licensee . However, a licensed medical
211-marijuana processor may process cannabis into a concentra ted form,
212-for a medical license holder, marijuana patient licensee for a fee.
213-Processors will Licensed medical marijuana processors shall be
214-required to complete a monthly yield and sales report to the
215-Oklahoma State Department of Health. This report will be due on the
216-15th fifteenth of each month and provide reporting on the previous
217-month. This report will shall detail the amount of marijuana
218-purchased in pounds, the amount of marijuana cooked or processed in
219-pounds, and the amount of waste in pounds. Additionally, this
220-report will shall show total wholesale sales in dollars. The
221-Oklahoma State Department of Health will shall have oversight and
222-
223-HB2660 HFLR Page 5
224-BOLD FACE denotes Committee Amendments. 1
225-2
226-3
227-4
228-5
229-6
230-7
231-8
232-9
233-10
234-11
235-12
236-13
237-14
238-15
239-16
240-17
241-18
242-19
243-20
244-21
245-22
246-23
247-24
248-
249-auditing responsibilities to ensure that all marijuana being grown
250-is accounted for. A licensed medical marijuana processor will shall
251-only be subject to a penalty if a gross discrepancy exists and
252-cannot be explained. Penalties for fraudulent reporting occurring
253-within any 2 year two-year time period will shall be an initial fine
254-of Five Thousand Dollars ($5, 000.00) (first) for a first offense and
255-revocation of licensing (second) the medial marijuana processor
256-license for a second offense .
257-D. The Department shall oversee inspection and compliance of
258-licensed medical marijuana processors producing products wit h
259-marijuana as an additive. The Oklahoma State Department of Health
260-will shall be compelled to, within thirty (30) days of passage of
261-this initiative, appoint a board of twelve (12) Oklahoma residents,
262-who are marijuana industry experts, to create a list of food safety
263-standards for processing and handling medical marijuana in Oklahoma.
264-These standards will shall be adopted by the agency Department and
265-the agency Department can enforce these standards for licensed
266-medical marijuana processors. The agency will Department shall
267-develop a standards review procedure and these standards can may be
268-altered by calling another board of twelve (12) Oklahoma marijuana
269-industry experts. A signed letter of twenty (20) operating licensed
270-medical marijuana processors would constitute a need for a new board
271-and standard standards review.
272-
273-HB2660 HFLR Page 6
274-BOLD FACE denotes Committee Amendments. 1
275-2
276-3
277-4
278-5
279-6
280-7
281-8
282-9
283-10
284-11
285-12
286-13
287-14
288-15
289-16
290-17
291-18
292-19
293-20
294-21
295-22
296-23
297-24
298-
299-E. If it becomes permissible , under federal law, marijuana may
300-be moved across state lines.
301-F. Any device used for the consumption of medical marijuana
302-shall be considered legal to be sold, manufactured, distributed, and
303-possessed. No merchant, wholesaler, manufacturer, or individual may
304-unduly be harassed or prosecuted for selling, manufacturing, or
305-possession of medical marijuana paraphernalia.
306-SECTION 2. AMENDATORY Section 17, Chapter 11, O.S.L.
307-2019, as amended by Section 4, Chapter 312, O.S.L. 2019 (63 O.S.
308-Supp. 2020, Section 427.17), is amended to read as follows:
309-Section 427.17 A. There is hereby created a medical marijuana
310-testing laboratory license as a category of the medical marijuana
311-business license. The Authority is hereby enabled to monitor,
312-inspect and audit a licensed testing laboratory under this act.
313-B. The Authority is hereby authorized to contract with a
314-private laboratory for the purp ose of conducting compliance testing
315-of medical marijuana testing laboratories licensed in this state.
316-Any such laboratory under contract for compliance testing shall be
317-prohibited from conducting any other commercial medical marijuana
318-testing in this state.
319-C. The Authority shall have the authority to develop acceptable
320-testing and research practices, including but not limited to
321-testing, standards, quality control analysis, equipment
322-certification and calibration, and chemical identification and
323-
324-HB2660 HFLR Page 7
325-BOLD FACE denotes Committee Amendments. 1
326-2
327-3
328-4
329-5
330-6
331-7
332-8
333-9
334-10
335-11
336-12
337-13
338-14
339-15
340-16
341-17
342-18
343-19
344-20
345-21
346-22
347-23
348-24
349-
350-substances used in bona fide research methods so long as it complies
351-with this act.
352-D. A person who is a direct beneficial owner or an indirect
353-beneficial owner of a medical marijuana dispensary, medical
354-marijuana commercial grower, or medical marijuana processo r shall
355-not be an owner of a laboratory.
356-E. A laboratory and a laboratory applicant shall comply with
357-all applicable local ordinances, including but not limited to
358-zoning, occupancy, licensing and building codes.
359-F. A separate license shall be required f or each specific
360-laboratory.
361-G. A medical marijuana testing laboratory license may be issued
362-to a person who performs testing and research on medical marijuana
363-and medical marijuana products for medical marijuana businesses,
364-medical marijuana research fac ilities, medical marijuana education
365-facilities, and testing and research on marijuana and marijuana
366-products grown or produced by a patient or caregiver on behalf of a
367-patient, upon verification of registration. No state -approved
368-medical marijuana testin g facility shall operate unless a medical
369-laboratory director is on site during operational hours.
370-H. A laboratory applicant shall comply with the application
371-requirements of this section and shall submit such other information
372-as required for a medical m arijuana business applicant, in addition
373-
374-HB2660 HFLR Page 8
375-BOLD FACE denotes Committee Amendments. 1
376-2
377-3
378-4
379-5
380-6
381-7
382-8
383-9
384-10
385-11
386-12
387-13
388-14
389-15
390-16
391-17
392-18
393-19
394-20
395-21
396-22
397-23
398-24
399-
400-to any information the Authority may request for initial approval
401-and periodic evaluations during the approval period.
402-I. A medical marijuana testing laboratory may accept samples of
403-medical marijuana, medical mari juana concentrate or medical
404-marijuana product from a medical marijuana business for testing and
405-research purposes only, which purposes may include the provision of
406-testing services for samples submitted by a medical marijuana
407-business for product developm ent. The Department may require a
408-medical marijuana business to submit a sample of medical marijuana,
409-medical marijuana concentrate or medical marijuana product to a
410-medical marijuana testing laboratory upon demand.
411-J. A medical marijuana testing laborat ory may accept samples of
412-medical marijuana, medical marijuana concentrate or medical
413-marijuana product from an individual person for testing only under
414-the following conditions:
415-1. The individual person is a patient or caregiver pursuant to
416-this act or is a participant in an approved clinical or
417-observational study conducted by a research facility; and
418-2. The medical marijuana testing laboratory shall require the
419-patient or caregiver to produce a valid patient license and current
420-and valid photo identifi cation.
421-K. A medical marijuana testing laboratory may transfer samples
422-to another medical marijuana testing laboratory for testing. All
423-laboratory reports provided to or by a medical marijuana business or
424-
425-HB2660 HFLR Page 9
426-BOLD FACE denotes Committee Amendments. 1
427-2
428-3
429-4
430-5
431-6
432-7
433-8
434-9
435-10
436-11
437-12
438-13
439-14
440-15
441-16
442-17
443-18
444-19
445-20
446-21
447-22
448-23
449-24
450-
451-to a patient or caregiver shall identify the medi cal marijuana
452-testing laboratory that actually conducted the test.
453-L. A medical marijuana testing laboratory may utilize a
454-licensed medical marijuana transporter to transport samples of
455-medical marijuana, medical marijuana concentrate and medical
456-marijuana product for testing, in accordance with this act and the
457-rules adopted pursuant thereto, between the originating medical
458-marijuana business requesting testing services and the destination
459-laboratory performing testing services.
460-M. The medical marijuana testing laboratory shall establish
461-policies to prevent the existence of or appearance of undue
462-commercial, financial or other influences that may diminish the
463-competency, impartiality and integrity of the testing processes or
464-results of the laboratory, or that may diminish public confidence in
465-the competency, impartiality and integrity of the testing processes
466-or results of the laboratory. At a minimum, employees, owners or
467-agents of a medical marijuana testing laboratory who participate in
468-any aspect of the analysis and results of a sample are prohibited
469-from improperly influencing the testing process, improperly
470-manipulating data, or improperly benefiting from any ongoing
471-financial, employment, personal or business relationship with the
472-medical marijuana business that provided the sample.
473-
474-HB2660 HFLR Page 10
475-BOLD FACE denotes Committee Amendments. 1
476-2
477-3
478-4
479-5
480-6
481-7
482-8
483-9
484-10
485-11
486-12
487-13
488-14
489-15
490-16
491-17
492-18
493-19
494-20
495-21
496-22
497-23
498-24
499-
500-N. The Department, pursuant to rules promulgated by the State
501-Commissioner of Health, shall develop standards, policies and
502-procedures as necessary for:
503-1. The cleanliness and orderliness of a laboratory premises and
504-the location of the laboratory in a secure location, and inspection,
505-cleaning and maintenance of any equipment or utensils used for the
506-analysis of test samples;
507-2. Testing procedures, testing standards for cannabinoid and
508-terpenoid potency and safe levels of contaminants, and remediation
509-procedures;
510-3. Controlled access areas for storage of medical marijuana and
511-medical marijuana product test samples, waste and reference
512-standards;
513-4. Records to be retained and computer systems to be utilized
514-by the laboratory;
515-5. The possession, storage and use by the laboratory of
516-reagents, solutions and reference standards;
517-6. A certificate of analysis (COA) for each lot of reference
518-standard;
519-7. The transport and disposal of unused marijuana, marijuana
520-products and waste;
521-8. The mandatory use by a laboratory of an inventory tracking
522-system to ensure all test batches or samples containing medical
523-marijuana, medical marijuana concentrate or medical marijuana
524-
525-HB2660 HFLR Page 11
526-BOLD FACE denotes Committee Amendments. 1
527-2
528-3
529-4
530-5
531-6
532-7
533-8
534-9
535-10
536-11
537-12
538-13
539-14
540-15
541-16
542-17
543-18
544-19
545-20
546-21
547-22
548-23
549-24
550-
551-products are identified and tracked from the point they are
552-transferred from a medical marijuana business, a patient or a
553-caregiver through the point of transfer, destruction or disposal.
554-The inventory tracking system reporting shall include the results of
555-any tests that are conducted on medical marijuana, medical marijuana
556-concentrate or medical marijuana product;
557-9. Standards of performance;
558-10. The employment of laboratory personnel;
559-11. A written standard operating procedure manual to be
560-maintained and updated by the laboratory;
561-12. The successful participa tion in a Department -approved
562-proficiency testing program for each testing category listed in this
563-section, in order to obtain and maintain certification;
564-13. The establishment of and adherence to a quality assurance
565-and quality control program to ensure sufficient monitoring of
566-laboratory processes and quality of results reported;
567-14. The establishment by the laboratory of a system to document
568-the complete chain of custody for samples from receipt through
569-disposal;
570-15. The establishment by the laborator y of a system to retain
571-and maintain all required records, including business records, and
572-processes to ensure results are reported in a timely and accurate
573-manner; and
574-
575-HB2660 HFLR Page 12
576-BOLD FACE denotes Committee Amendments. 1
577-2
578-3
579-4
580-5
581-6
582-7
583-8
584-9
585-10
586-11
587-12
588-13
589-14
590-15
591-16
592-17
593-18
594-19
595-20
596-21
597-22
598-23
599-24
600-
601-16. Any other aspect of laboratory testing of medical marijuana
602-or medical marijuana p roduct deemed necessary by the Department.
603-O. A medical marijuana testing laboratory shall promptly
604-provide the Department or designee of the Department access to a
605-report of a test and any underlying data that is conducted on a
606-sample at the request of a medical marijuana business or qualified
607-patient. A medical marijuana testing laboratory shall also provide
608-access to the Department or designee of the Department to laboratory
609-premises and to any material or information requested by the
610-Department to determine compliance with the requirements of this
611-section.
612-P. A medical marijuana testing laboratory shall retain all
613-results of laboratory tests conducted on marijuana or products for a
614-period of at least two (2) years and shall make them available to
615-the Department upon request.
616-Q. A medical marijuana testing laboratory shall test samples
617-from each harvest batch or product batch, as appropriate, of medical
618-marijuana, medical marijuana concentrate and medical marijuana
619-product for each of the following cat egories of testing, consistent
620-with standards developed by the Commissioner:
621-1. Microbials;
622-2. Mycotoxins;
623-3. Residual solvents;
624-4. Pesticides;
625-
626-HB2660 HFLR Page 13
627-BOLD FACE denotes Committee Amendments. 1
628-2
629-3
630-4
631-5
632-6
633-7
634-8
635-9
636-10
637-11
638-12
639-13
640-14
641-15
642-16
643-17
644-18
645-19
646-20
647-21
648-22
649-23
650-24
651-
652-5. Tetrahydrocannabinol (THC) and other cannabinoid potency;
653-6. Terpenoid potency; and
654-7. Heavy metals.
655-R. A test batch shall not exceed ten (10) pounds of usable
656-marijuana or medical marijuana product, as appropriate. A grower
657-shall separate each harvest lot of usable marijuana into harvest
658-batches containing no more than ten (10) twenty-five (25) pounds. A
659-processor shall separate each medical marijuana production lot into
660-production batches containing no more than ten (10) pounds four (4)
661-liters of distillate and for final products, the Oklahoma Medical
662-Marijuana Authority shall be authorized to promulga te rules on final
663-products as necessary. Provided, however, the Authority shall not
664-require testing of final products more often than every two hundred
665-(200) grams of THC, unless the batch size processed is less than two
666-hundred (200) grams of THC. As us ed in this subsection, "final
667-products" shall include, but not be limited to, cookies, brownies,
668-candies, gummies and chocolates .
669-S. Medical marijuana testing laboratory licensure shall be
670-contingent upon successful on -site inspection, successful
671-participation in proficiency testing and ongoing compliance with the
672-applicable requirements in this section.
673-T. A medical marijuana testing laboratory shall be inspected
674-prior to initial licensure and annually thereafter by an inspector
675-approved by the Authority .
676-
677-HB2660 HFLR Page 14
678-BOLD FACE denotes Committee Amendments. 1
679-2
680-3
681-4
682-5
683-6
684-7
685-8
686-9
687-10
688-11
689-12
690-13
691-14
692-15
693-16
694-17
695-18
696-19
697-20
698-21
699-22
700-23
701-24
702-
703-U. Beginning on a date determined by the Commissioner, not
704-later than January 1, 2020, medical marijuana testing laboratory
705-licensure shall be contingent upon accreditation by the NELAC
706-Institute (TNI), ANSI/ASQ National Accreditation Board or another
707-accrediting body approved by the Commissioner, and any applicable
708-standards as determined by the Department.
709-V. A commercial grower shall not transfer or sell medical
710-marijuana and a processor shall not transfer, sell or process into a
711-concentrate or produ ct any medical marijuana, medical marijuana
712-concentrate or medical marijuana product unless samples from each
713-harvest batch or production batch from which that medical marijuana,
714-medical marijuana concentrate or medical marijuana product was
715-derived has been tested by a medical marijuana testing facility for
716-contaminants and passed all contaminant tests required by this act.
717-SECTION 3. This act shall become effective November 1, 2021.
718-
719-COMMITTEE REPORT BY: COMMITTEE ON ALCOHOL, TOBACCO AND CONTROLLED
720-SUBSTANCES, dated 03/01/2021 - DO PASS, As Amended.
55+58-1-6480 GRS 01/10/21